| Date Filed | Type | Description |
| 08/24/2023 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on GERON CORP|
Txns:
| Bought 6,607 shares
@ $2.28, valued at
$15.1k
Bought 6,579 shares
@ $2.28, valued at
$15k
|
|
| 06/02/2023 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 125,000 options to buy
@ $3.27, valued at
$408.8k
|
|
| 05/30/2023 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on LENSAR, Inc.|
Txns:
| Granted 9,288 shares
@ $0
Granted 33,175 options to buy
@ $3.23, valued at
$107.2k
|
|
| 06/28/2022 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.81, valued at
$32.4k
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 22,677 options to buy
@ $2.92, valued at
$66.2k
|
|
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/29/2020 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 6,825 options to buy
@ $10, valued at
$68.3k
|
|
| 12/22/2020 |
3
| O'Farrell Elizabeth G. (Director) has filed a Form 3 on Inhibikase Therapeutics, Inc. |
| 11/24/2020 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 25,826 shares
@ $2.44, valued at
$63k
|
|
| 11/20/2020 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 63,291 shares
@ $2.381, valued at
$150.7k
|
|
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2020 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 83,000 options to buy
@ $1.54, valued at
$127.8k
|
|
| 01/13/2020 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on GERON CORP|
Txns:
| Bought 800 shares
@ $1.35, valued at
$1.1k
Bought 2,200 shares
@ $1.34, valued at
$2.9k
|
|
| 06/24/2019 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 126,050 options to buy
@ $3, valued at
$378.2k
|
|
| 06/07/2019 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 70,000 options to buy
@ $1.38, valued at
$96.6k
|
|
| 03/28/2019 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 120,000 options to buy
@ $1.68, valued at
$201.6k
|
|
| 03/28/2019 |
3
| O'Farrell Elizabeth G. (Director) has filed a Form 3 on GERON CORP |
| 06/25/2018 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 63,291 shares
@ $2.37, valued at
$150k
|
|
| 06/25/2018 |
3
| O'Farrell Elizabeth G. (Director) has filed a Form 3 on PDL BIOPHARMA, INC. |